Viking Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Viking Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • Viking Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$24.9M, a 10.7% decline year-over-year.
  • Viking Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$99.2M, a 22.6% decline year-over-year.
  • Viking Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$85.9M, a 24.7% decline from 2022.
  • Viking Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$68.9M, a 25.2% decline from 2021.
  • Viking Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$55M, a 39.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$99.2M -$24.9M -$2.41M -10.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-23
Q2 2024 -$96.7M -$22.3M -$3.03M -15.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-24
Q1 2024 -$93.7M -$27.4M -$7.83M -40.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$85.9M -$24.6M -$5.05M -25.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 -$80.8M -$22.5M -$6.76M -42.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-23
Q2 2023 -$74.1M -$19.2M -$1.79M -10.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-24
Q1 2023 -$72.3M -$19.5M -$3.43M -21.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$68.9M -$19.6M -$7.2M -58.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 -$61.7M -$15.8M -$2.53M -19.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 -$59.1M -$17.4M -$2.05M -13.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-26
Q1 2022 -$57.1M -$16.1M -$2.09M -14.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 -$55M -$12.4M -$1.41M -12.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 -$53.6M -$13.2M -$3.96M -42.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$49.6M -$15.4M -$5.81M -60.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 -$43.8M -$14M -$4.32M -44.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 -$39.5M -$10.9M -$3.5M -47% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-09
Q3 2020 -$36M -$9.29M -$3.56M -62.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$32.4M -$9.57M -$1.9M -24.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 -$30.5M -$9.69M -$4.76M -96.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 -$25.8M -$7.45M -$2.21M -42.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-17
Q3 2019 -$23.6M -$5.73M +$869K +13.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 -$24.4M -$7.67M -$1M -15% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$23.4M -$4.92M -$1.37M -38.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 -$22.1M -$5.24M -$1.16M -28.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$20.9M -$6.6M -$501K -8.21% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$20.4M -$6.67M -$1.5M -29% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$18.9M -$3.55M +$1.67M +32% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$20.6M -$4.09M -$440K -12.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$20.1M -$6.1M -$2.29M -60.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$17.8M -$5.17M -$1.48M -40.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$16.4M -$5.22M -$1.64M -45.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$14.7M -$3.64M +$1.45M +28.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$16.2M -$3.81M +$929K +19.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$17.1M -$3.69M +$4.17M +53% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$21.3M -$3.59M +$2.12M +37.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$23.4M -$5.09M -$6.48M -466% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-21
Q3 2015 -$16.9M -$4.74M -$4.47M -1709% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$12.4M -$7.87M +$14.9M +65.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$27.4M -$5.71M -$5.48M -2395% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$21.9M $1.39M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$262K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$22.8M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$229K Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.